Contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biotechnologie, and an independent specialist for aseptic fill and finish services, Rentschler Fill Solutions, have announced a strategic partnership to provide a new fill and finish facility.
One stop shop
The facility will be based at Rentschler Fill Solutions, which will begin operations next year. Additionally, it will serve as the exclusive partner for the fill and finish services of Rentschler Biotechnologie’s manufacturing projects.
“Based on the maturity of the biotech industry and demand for new drugs in growing international markets, we are also seeing more and more demand not only in terms of manufacturing for clinical studies but for commercial-scale manufacturing and market supply,” said Dr Frank Mathias, CEO of Rentschler Biotechnologie. Rentschler Biotechnologie is continually seeking and improving ways to help clients achieve their goals, all along the value chain — from cell line development through finished products. This partnership also supports our recent strategic alliance with Leukocare, as improved formulation strategies will contribute to the quality of the fill and finish process. Both partnerships will enable us to serve our clients as they grow.”
Based in Austria, the new facility will house advanced aspetic filling technology and will be compliant with regulatory standards. Additionally, it has been designed to accommodate further future expansions without causing disruptions to operations.